NCT00042900View on ClinicalTrials.gov

Pyroxamide in Treating Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 2002

Primary Completion Date

September 30, 2002

Study Completion Date

September 30, 2002

Conditions
Chronic Myeloproliferative DisordersLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesPrecancerous ConditionSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

pyroxamide

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00042900 - Pyroxamide in Treating Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter